881851-50-9,MFCD31630844
Catalog No.:AA01CC09

881851-50-9 | Larazotide Acetate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
98% by HPLC
in stock  
$179.00   $125.00
- +
10mg
98% by HPLC
in stock  
$258.00   $180.00
- +
25mg
98% by HPLC
in stock  
$473.00   $331.00
- +
50mg
98% by HPLC
in stock  
$761.00   $533.00
- +
100mg
98% by HPLC
in stock  
$1,270.00   $889.00
- +
500mg
98% by HPLC
in stock  
$3,958.00   $2,771.00
- +
1000mg
98% by HPLC
in stock  
$6,295.00   $4,407.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01CC09
Chemical Name:
Larazotide Acetate
CAS Number:
881851-50-9
Molecular Formula:
C34H59N9O12
Molecular Weight:
785.8854
MDL Number:
MFCD31630844
SMILES:
CC(=O)O.NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)CCC(=O)N)C(C)C)CC(C)C)C(C)C
Properties
Computed Properties
 
Complexity:
1320  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
5  
Heavy Atom Count:
55  
Hydrogen Bond Acceptor Count:
13  
Hydrogen Bond Donor Count:
10  
Rotatable Bond Count:
21  

Literature

Title: AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501

Title: Co-administration with the pharmacological chaperone AT1001 increases recombinant human α-galactosidase A tissue uptake and improves substrate reduction in Fabry mice.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy 20120401

Title: The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001.

Journal: The Journal of pharmacy and pharmacology 20120101

Title: Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse.

Journal: Gut 20080101

Title: The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study.

Journal: Alimentary pharmacology & therapeutics 20070901

Title: Gopalakrishnan S, et al. Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides. 2012 May;35(1):86-94.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:881851-50-9 Molecular Formula|881851-50-9 MDL|881851-50-9 SMILES|881851-50-9 Larazotide Acetate
Catalog No.: AA01CC09
881851-50-9,MFCD31630844
881851-50-9 | Larazotide Acetate
Pack Size: 5mg
Purity: 98% by HPLC
in stock
$179.00 $125.00
Pack Size: 10mg
Purity: 98% by HPLC
in stock
$258.00 $180.00
Pack Size: 25mg
Purity: 98% by HPLC
in stock
$473.00 $331.00
Pack Size: 50mg
Purity: 98% by HPLC
in stock
$761.00 $533.00
Pack Size: 100mg
Purity: 98% by HPLC
in stock
$1,270.00 $889.00
Pack Size: 500mg
Purity: 98% by HPLC
in stock
$3,958.00 $2,771.00
Pack Size: 1000mg
Purity: 98% by HPLC
in stock
$6,295.00 $4,407.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01CC09
Chemical Name: Larazotide Acetate
CAS Number: 881851-50-9
Molecular Formula: C34H59N9O12
Molecular Weight: 785.8854
MDL Number: MFCD31630844
SMILES: CC(=O)O.NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)CCC(=O)N)C(C)C)CC(C)C)C(C)C
Properties
Complexity: 1320  
Covalently-Bonded Unit Count: 2  
Defined Atom Stereocenter Count: 5  
Heavy Atom Count: 55  
Hydrogen Bond Acceptor Count: 13  
Hydrogen Bond Donor Count: 10  
Rotatable Bond Count: 21  
Literature fold

Title: AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20120501

Title: Co-administration with the pharmacological chaperone AT1001 increases recombinant human α-galactosidase A tissue uptake and improves substrate reduction in Fabry mice.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy20120401

Title: The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001.

Journal: The Journal of pharmacy and pharmacology20120101

Title: Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse.

Journal: Gut20080101

Title: The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study.

Journal: Alimentary pharmacology & therapeutics20070901

Title: Gopalakrishnan S, et al. Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides. 2012 May;35(1):86-94.

Building Blocks More >
115-29-7
115-29-7
6,9-Methano-2,4,3-benzodioxathiepin,6,7,8,9,10,10-hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide
AA01CC3A | MFCD00137651
1450828-98-4
1450828-98-4
(1R,2S,5R)-(-)-Menthol-d4
AA01CC63
1173023-51-2
1173023-51-2
Bufuralol-d9 Hydrochloride
AA01CC9S | MFCD09840134
6804-07-5
6804-07-5
Hydrazinecarboxylic acid, [(1,4-dioxido-2-quinoxalinyl)methylene]-,methyl ester
AA01CCDA | MFCD00057293
1133210-23-7
1133210-23-7
(R)-Cetirizine-d4 Dihydrochloride
AA01CCGD
1330171-36-2
1330171-36-2
Tianeptine Metabolite MC5-d4 Sodium Salt
AA01CCJX | MFCD18425614
218144-98-0
218144-98-0
N'1-(3,4-dichlorobenzylidene)-4-methylbenzene-1-sulfonohydrazide
AA01CDWP | MFCD00115921
1240608-82-5
1240608-82-5
2-Bromooxazole-4-carbonitrile
AA01DD98 | MFCD16989414
2061996-69-6
2061996-69-6
(R)-5-BROMO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YLAMINE HYDROCHLORIDE
AA01DDSM | MFCD26586044
862667-62-7
862667-62-7
3-(Benzyloxy)-4-Oxo-6-(((Tetrahydro-2H-Pyran-2-Yl)Oxy)Methyl)-4H-Pyran-2-Carboxylic Acid
AA01DFP4 | MFCD30471962
Submit
© 2017 AA BLOCKS, INC. All rights reserved.